en Experimental Neurobiology

Cited by CrossRef (21)

  1. Milena Stevanovic, Natasa Kovacevic-Grujicic, Isidora Petrovic, Danijela Drakulic, Milena Milivojevic, Marija Mojsin. Crosstalk between SOX Genes and Long Non-Coding RNAs in Glioblastoma. IJMS 2023;24:6392
    https://doi.org/10.3390/ijms24076392
  2. Karolina Frąszczak, Bartłomiej Barczyński. The Role of Cancer Stem Cell Markers in Ovarian Cancer. Cancers 2023;16:40
    https://doi.org/10.3390/cancers16010040
  3. Xiao‐liang Wang, Bao‐hua Jiao, Jian‐liang Wu, Jian‐kai Yang, Yu‐hua Hu, Kai Cui. Mechanism of RIP2 enhancing stemness of glioma cells induces temozolomide resistance. CNS Neurosci Ther 2022;28:2319
    https://doi.org/10.1111/cns.13981
  4. Xiangdong Liang, Bin Liu. Exploration of PVT1 as a biomarker in prostate cancer. 2024;103:e39406
    https://doi.org/10.1097/MD.0000000000039406
  5. Arya Moftakhar, Seyed Esmaeil Khoshnam, Maryam Farzaneh. The Pathogenic Roles of lncRNAs in Glioma. CCTR 2024;20:12
    https://doi.org/10.2174/1573394719666230316112549
  6. Qiang Wang, Chunmei Zhang, Shengya Cao, Hongying Zhao, Rongke Jiang, Yanfang Li. Tumor-derived exosomes orchestrate the microRNA-128-3p/ELF4/CDX2 axis to facilitate the growth and metastasis of gastric cancer via delivery of LINC01091. Cell Biol Toxicol 2023;39:519
    https://doi.org/10.1007/s10565-022-09728-y
  7. Sanchit Gandhi, Ashish Bhushan, Unmesh Shukla, Amit Pundir, Sanjeev Singh, Tapasya Srivastava. Downregulation of lncRNA SNHG1 in hypoxia and stem cells is associated with poor disease prognosis in gliomas . Cell Cycle 2023;22:1135
    https://doi.org/10.1080/15384101.2023.2191411
  8. Jianwei Li, Zhenwu Yang, Duanyang Wang, Zhiguang Li. WAFNRLTG: A Novel Model for Predicting LncRNA Target Genes Based on Weighted Average Fusion Network Representation Learning Method. Front. Cell Dev. Biol. 2022;9
    https://doi.org/10.3389/fcell.2021.820342
  9. Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, Seyed reza Mirmazloomi, Aria Hassanpoor, Maryam Aboutalebi, Shamin Rezaei, Elahe Sadat Hejazi, Amirabbas Kakavand, Hajar Heidari, Shokooh Salimimoghadam, Afshin Taheriazam, Mehrdad Hashemi, Saeed Samarghandian. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response. Biomedicine & Pharmacotherapy 2022;156:113860
    https://doi.org/10.1016/j.biopha.2022.113860
  10. João Basso, Ana Fortuna, Rui Vitorino, Nobuyoshi Akimitsu, Carla Vitorino. New Insights Into Glioblastoma. 2022.
    https://doi.org/10.1016/B978-0-323-99873-4.00028-1
  11. Dacheng Liu, Xuechao Zhao, Qiang Zhang, Fei Zhou, Xiangyang Tong. Bone marrow mesenchymal stem cell-derived exosomes promote osteoblast proliferation, migration and inhibit apoptosis by regulating KLF3-AS1/miR-338-3p. BMC Musculoskelet Disord 2024;25
    https://doi.org/10.1186/s12891-024-07236-0
  12. Aryan Rezaee, Pooya M. Tehrany, Farimah Jafari Tirabadi, Negin Sanadgol, Asal Sadat Karimi, Atra Ajdari, Sepideh Eydivandi, Sara Etemad, Romina Rajabi, Parham Rahmanian, Ramin Khorrami, Noushin Nabavi, Amir Reza Aref, Xiaoping Fan, Rongjun Zou, Mohsen Rashidi, Mohammad Arad Zandieh, Kiavash Hushmandi. Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAs. Biomedicine & Pharmacotherapy 2023;165:115187
    https://doi.org/10.1016/j.biopha.2023.115187
  13. Yuxiang Liao, Xiaohui Qiu, Jingping Liu, Zhiping Zhang, Bo Liu, Chen Jin. The role of m6A‐modified CircEPHB4 in glioma pathogenesis: Insights into cancer stemness metastasis. Ann Clin Transl Neurol 2023;10:1749
    https://doi.org/10.1002/acn3.51864
  14. Jungwook Roh, Mijung Im, JiHoon Kang, BuHyun Youn, Wanyeon Kim. Long non-coding RNA in glioma: novel genetic players in temozolomide resistance. Animal Cells and Systems 2023;27:19
    https://doi.org/10.1080/19768354.2023.2175497
  15. Bianca Oana Pirlog, Silvina Ilut, Radu Pirlog, Paul Chiroi, Andreea Nutu, Delia Ioana Radutiu, George Daniel Cuc, Ioana Berindan-Neagoe, Seyed Fazel Nabavi, Rosanna Filosa, Seyed Mohammad Nabavi. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs. Expert Rev. Mol. Med. 2023;25
    https://doi.org/10.1017/erm.2023.10
  16. Pouya Goleij, Ghazaleh Pourali, Arash Raisi, Fatemeh Ravaei, Shahin Golestan, Atena Abed, Zahra Sadat Razavi, Fatemeh Zarepour, Seyed Pouya Taghavi, Sahar Ahmadi Asouri, Moein Rafiei, Seyed Mojtaba Mousavi, Michael R. Hamblin, Sahand Talei, Amirhossein Sheida, Hamed Mirzaei. Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide. Mol Neurobiol 2024
    https://doi.org/10.1007/s12035-024-04316-z
  17. Ruiming Li, Xia Wang, Chunming Zhu, Kefeng Wang. lncRNA PVT1: a novel oncogene in multiple cancers. Cell Mol Biol Lett 2022;27
    https://doi.org/10.1186/s11658-022-00385-x
  18. Rasmani Hazra, Rinku Debnath, Arati Tuppad. Glioblastoma stem cell long non-coding RNAs: therapeutic perspectives and opportunities. Front. Genet. 2024;15
    https://doi.org/10.3389/fgene.2024.1416772
  19. Manendra Singh Tomar, Ashok Kumar, Chhitij Srivastava, Ashutosh Shrivastava. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021;1876:188616
    https://doi.org/10.1016/j.bbcan.2021.188616
  20. Li Zhang, Xue-Zhen Feng, Zhuan-Quan Xiao, Guo-Rong Fan, Shang-Xing Chen, Sheng-Liang Liao, Hai Luo, Zong-De Wang. Design, Synthesis, Antibacterial, Antifungal and Anticancer Evaluations of Novel β-Pinene Quaternary Ammonium Salts. IJMS 2021;22:11299
    https://doi.org/10.3390/ijms222011299
  21. Weiping Yao, Shuang Li, Ruiqi Liu, Mingyun Jiang, Liang Gao, Yanwei Lu, Xiaodong Liang, Haibo Zhang. Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer. Front. Oncol. 2022;12
    https://doi.org/10.3389/fonc.2022.959208